Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Hypertrophy, Left Ventricular

n(6)-carboxymethyllysine has been researched along with Hypertrophy, Left Ventricular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busch, M; Franke, C; Franke, S; Müller, A; Niwa, T; Stein, G; Wendt, T1

Other Studies

1 other study(ies) available for n(6)-carboxymethyllysine and Hypertrophy, Left Ventricular

ArticleYear
Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:3 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors

2003